STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Income Statement [Abstract]
Grant income	$ 476,556	$ 0
OPERATING EXPENSES:
Research and development	9,400,306	15,606,985
General & administrative	7,848,496	5,800,348
Total operating expenses	17,248,802	21,407,333
OPERATING LOSS	(16,772,246)	(21,407,333)
Other income	70,896	69,020
(Loss) gain on derivative instruments	(8,643,561)	11,007,215
Interest expense, net	(6,492,294)	(4,032,189)
Net loss	(31,837,205)	(14,363,287)
Modification of warrants	(14,368)	(63,768)
Net loss available to common shareholders	$ (31,851,573)	$ (14,427,055)
NET LOSS PER COMMON SHARE
BASIC	$ (1.87)	$ (1.83)
DILUTED	$ (1.87)	$ (1.91)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING
BASIC	17,004,722	7,891,843
DILUTED	17,004,722	7,902,647